Robert B. Parker

3.3k total citations · 2 hit papers
100 papers, 2.6k citations indexed

About

Robert B. Parker is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Robert B. Parker has authored 100 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 18 papers in Cardiology and Cardiovascular Medicine and 17 papers in Surgery. Recurrent topics in Robert B. Parker's work include Neurotransmitter Receptor Influence on Behavior (11 papers), Forensic Toxicology and Drug Analysis (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Robert B. Parker is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (11 papers), Forensic Toxicology and Drug Analysis (10 papers) and Pharmacogenetics and Drug Metabolism (9 papers). Robert B. Parker collaborates with scholars based in United States, United Kingdom and Australia. Robert B. Parker's co-authors include D. R. Waud, S. Casey Laizure, Zheyi Hu, Vanessa L. Herring, Linda L. Coughenour, J R McLean, Jerry L. Bauman, Judith E. Soberman, Timothy D. Mandrell and Karen J. Beckman and has published in prestigious journals such as Circulation, PLoS ONE and Clinical Cancer Research.

In The Last Decade

Robert B. Parker

95 papers receiving 2.4k citations

Hit Papers

PHARMACOLOGICAL ESTIMATION OF DRUG-RECEPTOR DISSOCIATION ... 1971 2026 1989 2007 1971 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert B. Parker United States 27 779 477 453 375 326 100 2.6k
Ulf Bondesson Sweden 33 674 0.9× 363 0.8× 503 1.1× 111 0.3× 259 0.8× 156 3.8k
Gail D. Anderson United States 43 867 1.1× 412 0.9× 471 1.0× 281 0.7× 290 0.9× 109 6.0k
Roberto Goméni Italy 33 582 0.7× 434 0.9× 718 1.6× 229 0.6× 199 0.6× 179 3.3k
Andrew Fitton United Kingdom 34 758 1.0× 407 0.9× 597 1.3× 438 1.2× 518 1.6× 53 4.1k
David Foster Australia 31 1.2k 1.5× 149 0.3× 333 0.7× 168 0.4× 369 1.1× 109 4.0k
Jan de Hoon Belgium 35 310 0.4× 346 0.7× 657 1.5× 180 0.5× 352 1.1× 180 3.6k
Sidney A. Spector United States 18 785 1.0× 254 0.5× 354 0.8× 217 0.6× 145 0.4× 40 2.4k
Mladen V. Tzvetkov Germany 31 781 1.0× 208 0.4× 472 1.0× 161 0.4× 269 0.8× 122 3.3k
Reynold Spector United States 43 1.4k 1.8× 890 1.9× 486 1.1× 216 0.6× 270 0.8× 181 5.8k
Susan M. Pond Australia 35 1.3k 1.6× 334 0.7× 541 1.2× 165 0.4× 440 1.3× 161 4.4k

Countries citing papers authored by Robert B. Parker

Since Specialization
Citations

This map shows the geographic impact of Robert B. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Parker more than expected).

Fields of papers citing papers by Robert B. Parker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Parker. The network helps show where Robert B. Parker may publish in the future.

Co-authorship network of co-authors of Robert B. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Robert B. Parker. A scholar is included among the top collaborators of Robert B. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert B. Parker. Robert B. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Laizure, S. Casey & Robert B. Parker. (2019). Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine?. Xenobiotica. 50(1). 92–100. 10 indexed citations
3.
Deal, Eli N., Paul M. Stranges, Whitney D. Maxwell, et al.. (2016). The Importance of Research and Scholarly Activity in Pharmacy Training. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(12). e200–e205. 49 indexed citations
4.
Patnaik, Amita, Glen J. Weiss, John E. Leonard, et al.. (2015). Safety, Pharmacokinetics, and Pharmacodynamics of a Humanized Anti-Semaphorin 4D Antibody, in a First-In-Human Study of Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(4). 827–836. 50 indexed citations
5.
Parker, Robert B., Zheyi Hu, Bernd Meibohm, & S. Casey Laizure. (2014). Effects of Alcohol on Human Carboxylesterase Drug Metabolism. Clinical Pharmacokinetics. 54(6). 627–638. 34 indexed citations
6.
Spivey, Christina A., et al.. (2014). Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation. Value in Health. 17(7). A763–A763. 10 indexed citations
7.
Laizure, S. Casey, Robert B. Parker, Vanessa L. Herring, & Zheyi Hu. (2013). Identification of Carboxylesterase-Dependent Dabigatran Etexilate Hydrolysis. Drug Metabolism and Disposition. 42(2). 201–206. 81 indexed citations
9.
Hu, Zheyi, Robert B. Parker, Vanessa L. Herring, & S. Casey Laizure. (2012). Conventional liquid chromatography/triple quadrupole mass spectrometry based metabolite identification and semi-quantitative estimation approach in the investigation of in vitro dabigatran etexilate metabolism. Analytical and Bioanalytical Chemistry. 405(5). 1695–1704. 37 indexed citations
10.
Laizure, S. Casey & Robert B. Parker. (2010). A comparison of the metabolism of clopidogrel and prasugrel. Expert Opinion on Drug Metabolism & Toxicology. 6(11). 1417–1424. 14 indexed citations
11.
Boucher, Bradley A., Peter A. Chyka, Lawrence J. Hak, et al.. (2006). A Comprehensive Approach to Faculty Development. American Journal of Pharmaceutical Education. 70(2). 27–27. 28 indexed citations
12.
Parker, Robert B., Charles R. Yates, S. Casey Laizure, & Karl T. Weber. (2006). P-Glycoprotein Modulates Aldosterone Plasma Disposition and Tissue Uptake. Journal of Cardiovascular Pharmacology. 47(1). 55–59. 21 indexed citations
13.
Lewis, Daniel D., Lisa Neuwirth, Robert B. Parker, et al.. (1999). Radiographic evaluation of elbow joints before and after surgery in dogs with possible fragmented medial coronoid process. Journal of the American Veterinary Medical Association. 214(1). 52–58. 32 indexed citations
14.
Lewis, Daniel D., et al.. (1998). Effect of radiographic positioning on interpretation of cubital joint congruity in dogs. American Journal of Veterinary Research. 59(11). 1351–1351. 29 indexed citations
15.
Lewis, Daniel D., et al.. (1997). Results of Screw/Wire/Polymethylmethacrylate Composite Fixation for Acetabular Fracture Repair in 14 Dogs. Veterinary Surgery. 26(3). 223–234. 31 indexed citations
16.
Parker, Robert B., S. Casey Laizure, Cheri Williams, Timothy D. Mandrell, & John J. Lima. (1997). EVALUATION OF DOSE-DEPENDENT PHARMACOKINETICS OF COCAETHYLENE AND COCAINE IN CONSCIOUS DOGS. Life Sciences. 62(4). 333–342. 10 indexed citations
17.
Parker, Robert B., et al.. (1996). Effects of ethanol and cocaethylene on cocaine pharmacokinetics in conscious dogs.. Drug Metabolism and Disposition. 24(8). 850–853. 20 indexed citations
18.
Parker, Robert B., et al.. (1986). OSTEOSARCOMA WITH A PATHOLOGIC FRACTURE IN A SIX‐MONTH‐OLD DOG. Veterinary Radiology. 27(1). 18–19. 3 indexed citations
19.
Parker, Robert B.. (1972). MEASUREMENT OF DRUG-RECEPTOR DISSOCIATION CONSTANTS OF MUSCARINIC AGONISTS ON INTESTINAL SMOOTH MUSCLE. Journal of Pharmacology and Experimental Therapeutics. 180(1). 62–70. 13 indexed citations
20.
Waud, D. R. & Robert B. Parker. (1971). PHARMACOLOGICAL ESTIMATION OF DRUG-RECEPTOR DISSOCIATION CONSTANTS. STATISTICAL EVALUATION. II. COMPETITIVE ANTAGONISTS. Journal of Pharmacology and Experimental Therapeutics. 177(1). 13–24. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026